Molecular Diagnostics Market Decoding the Future of Personalized Healthcare and Forecast 2030 | Becton, Dickinson and Company,  Agilent Technologies, Inc

Market Overview:

Molecular diagnostics examines biomarkers at the DNA, RNA and protein level to identify disease states and detect other health conditions. It is used for conditions such as infectious diseases, oncology and genetic testing.

Market Dynamics:

The molecular diagnostics market is driven by increasing demand for personalized medicine and growing infectious disease prevalence. Personalized medicine tailors healthcare to individual variability in genes, environment and lifestyle of each patient. It enables early detection and prevention of diseases through molecular diagnosis and targets treatment based on individual molecular profiles. Moreover, rising incidence of infectious diseases globally is also propelling market growth. According to the World Health Organization (WHO), infectious diseases account for around 26% of global deaths. Molecular diagnostic technologies help identify disease-causing pathogens quickly and guide appropriate treatment.

Market Drivers

Increasing Demand for Personalized Medicine

Personalized medicine focuses on individual variation in genes, environment, and lifestyle for each person. It helps determine prevention and treatment approaches for conditions like cancer, heart disease, and mental health disorders. Molecular diagnostics play a major role in personalized medicine by providing information on biomarkers and genetic variations that determine disease risk and treatment response in each individual. This has led to increased demand for molecular diagnostic tests that help characterize diseases and select appropriate treatments tailored to individual patient needs.

Get an Exclusive Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/1545

Rising Incidence of Infectious Diseases and Cancer Globally

Infectious diseases like HIV, hepatitis, tuberculosis continue to pose major public health challenges globally. Similarly, cancer has also emerged as one of the leading causes of mortality worldwide. Molecular diagnostics help identify infectious pathogens, monitor disease progression, detect cancer at early stages, and select optimal therapies. The increasing disease burden of infections and cancer has fueled the need for accurate and rapid molecular diagnostic tests for improved disease management and patient outcomes. This growing clinical demand has become a key market driver for the molecular diagnostics industry.

Market Restrain

High Cost of Molecular Diagnostic Tests

Molecular diagnostic techniques require specialized equipment, well-trained staff, and advanced infrastructure. This makes molecular diagnostic tests relatively expensive compared to conventional diagnostic methods. The high costs pose affordability challenges, especially in low-resource settings. Furthermore, the need for repeat and follow-up testing increases the overall costs incurred on molecular diagnostics over time. Cost-effectiveness often determines reimbursement and commercial adoption of new molecular diagnostic tests. However, high prices limit their widespread use in disease management and screening programs. This cost hurdle remains a major market restraint for molecular diagnostics.

Opportunity

Point-of-Care Molecular Diagnostics

Traditionally, molecular diagnostic tests require well-equipped central laboratories and qualified technicians for complex assay procedures. This limits their use largely to hospitals and reference laboratories. However, the development of portable, rapid, user-friendly, and affordable molecular diagnostic platforms is transforming diagnostics from centralized to point-of-care settings. POC molecular diagnostics enable testing at doctors' offices, clinics, homes, and in remote areas with limited resources. This decentralized testing approach presents new market opportunities for molecular diagnostics by improving access, time to diagnosis, treatment decisions, and patient outcomes. Miniaturization of molecular diagnostic devices makes point-of-care testing a promising opportunity area.

Market Trend

Adoption of Next-Generation Sequencing Technologies

Currently, most molecular diagnostic tests use targeted methods like PCR, transcription-mediated amplification etc. to detect specific genetic mutations or pathogens. However, next-generation sequencing (NGS) technologies allow large-scale, untargeted, and comprehensive analysis of genomes, transcriptomes, and epigenomes. NGS can detect hundreds to millions of genetic variations simultaneously in a cost-effective manner. This has fueled the adoption of clinical NGS assays for complex analyses like cancer genome profiling and infectious disease identification. NGS is expected to transform diseases diagnosis, treatment selection as well as disease monitoring over time. Rising adoption of NGS across various applications indicates this to be a major emerging trend in the molecular diagnostics market.

List of TOP Players in Market Report are: -

◘ Hologic,Inc.
◘ Grifols
◘ S.A.
◘ Abbott Laboratories
◘ Qiagen N.V.
◘ F. Hoffmann-La Roche Ltd.
◘ Siemens Healthineers
◘ Becton
◘ Dickinson and Company
◘ Agilent Technologies Inc.
◘ Meridian
◘ Cepheid
◘ and Beckman Coulter Inc.

Note: Major Players are sorted in no particular order.

Market Detailed Segmentation:

By Product Type:

Reagents & Kits (Consumables)
Instruments

By Application:

Oncology
Genetic Testing
Microbiology
STDs
Blood Screening
Virology
Tissue Typing
Prenatal Diagnosis
Others

By End User:

Hospitals
Diagnostic Laboratories
Academic and Research Labs
Others

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/1545

Furthermore, the years considered for the study are as follows:

Historical data - 2016-2021
The base year for estimation - is 2021
Estimated Year - 2023
Forecast period** - 2023 to 2030

This Molecular Diagnostics Market Research/Analysis Report Contains Answers to your following Questions:

◈What are the current global trends in the Molecular Diagnostics market, and will the market experience an increase or decrease in demand in the upcoming years?

◈ What is the expected demand for various product types within the Molecular Diagnostics market, and what are the emerging Market applications and trends?

◈ What are the projections for the global Molecular Diagnostics Market in terms of capacity, production, production value, cost, profit, market share, supply, consumption, import, and export?

◈ How will strategic developments shape the Market trajectory in the medium to long term?

◈ What factors contribute to the final price of Molecular Diagnostics , and what are the raw materials used in its manufacturing?

◈ What is the market's growth potential, particularly with the increasing adoption of Molecular Diagnostics in mining?

◈ What is the current and 2022 value of the global market, and who are the leading companies in this market?

◈ What recent Market trends can be leveraged to create additional revenue streams?

◈ What entry strategies, economic impact mitigation measures, and marketing channels should be considered for the Molecular Diagnostics Market?

Summarized Extracts from TOC of Market Study

Chapter 1 Molecular Diagnostics Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Molecular Diagnostics

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Molecular Diagnostics industry

1.4 Methodology of The Study

1.5 Research Data Source

Chapter 2 Executive Summary

Chapter 3 Industry Chain Analysis

Chapter 4 Market, by Type

Chapter 5 Market, by Application

Chapter 6 Market Analysis by Regions

Chapter 7 North America Market Analysis by Countries

Chapter 8 Europe Molecular Diagnostics Market Analysis by Countries

Chapter 9 Asia Pacific Molecular Diagnostics Market Analysis by Countries

Chapter 10 Middle East and Africa Molecular Diagnostics Market Analysis by Countries

Chapter 11 South America Molecular Diagnostics Market Analysis by Countries

Chapter 12 Competitive Landscape

Chapter 13 Industry Outlook

Chapter 14 Market Forecast

Chapter 15 New Project Feasibility Analysis

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.